HAL vs VYNE · P/E 9.3, $19.05B cap vs rev $501.0K
Halliburton Company (HAL) versus Vyne Therapeutics Inc (VYNE) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Vyne Therapeutics Inc (VYNE) is a biotechnology company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported VYNE revenue for 2024-12-31 was $501.0K. Net income was -$39.8M. Revenue was up 18.2% from 2023-12-31 to 2024-12-31. VYNE currently screens at market cap $21.1M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. VYNE currently screens at market cap $21.1M.
Not investment advice. Open the HAL and VYNE stock pages for the full models.
Not investment advice.